Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
168, P. 115669 - 115669
Published: Oct. 10, 2023
Diabetic
cardiomyopathy
is
a
chronic
cardiovascular
complication
caused
by
diabetes
that
characterized
changes
in
myocardial
structure
and
function,
ultimately
leading
to
heart
failure
even
death.
Mitochondria
serve
as
the
provider
of
energy
cardiomyocytes,
mitochondrial
dysfunction
plays
central
role
development
diabetic
cardiomyopathy.
In
response
series
pathological
dysfunction,
quality
control
system
activated.
The
(including
biogenesis,
fusion
fission,
mitophagy)
core
maintaining
normal
mitochondria
performing
their
physiological
functions.
However,
abnormal
cardiomyopathy,
resulting
insufficient
excessive
fission
within
cardiomyocyte,
fragmented
are
not
phagocytosed
timely
manner,
accumulating
cardiomyocyte
injury.
Currently,
there
no
specific
therapy
or
prevention
for
glycemic
remains
mainstay.
this
review,
we
first
elucidate
pathogenesis
explore
link
between
Then,
summarize
how
clinically
used
hypoglycemic
agents
sodium-glucose
cotransport
protein
2
inhibitions,
glucagon-like
peptide-1
receptor
agonists,
dipeptidyl
peptidase-4
inhibitors,
thiazolidinediones,
metformin,
α-glucosidase
inhibitors)
exert
cardioprotective
effects
treat
prevent
targeting
system.
addition,
mechanisms
complementary
alternative
therapies,
such
active
ingredients
traditional
Chinese
medicine,
exercise,
lifestyle,
treatment
also
added,
which
lays
foundation
excavation
new
drugs.
Circulation,
Journal Year:
2022,
Volume and Issue:
146(18), P. 1383 - 1405
Published: Oct. 31, 2022
SGLT2
(sodium-glucose
cotransporter
2)
inhibitors
produce
a
distinctive
pattern
of
benefits
on
the
evolution
and
progression
cardiomyopathy
nephropathy,
which
is
characterized
by
reduction
in
oxidative
endoplasmic
reticulum
stress,
restoration
mitochondrial
health
enhanced
biogenesis,
decrease
proinflammatory
profibrotic
pathways,
preservation
cellular
organ
integrity
viability.
A
substantial
body
evidence
indicates
that
this
characteristic
responses
can
be
explained
action
to
promote
housekeeping
enhancing
autophagic
flux,
an
effect
may
related
these
drugs
simultaneous
upregulation
nutrient
deprivation
signaling
downregulation
surplus
signaling,
as
manifested
increase
expression
activity
AMPK
(adenosine
monophosphate-activated
protein
kinase),
SIRT1
(sirtuin
1),
SIRT3
3),
SIRT6
6),
PGC1-α
(peroxisome
proliferator-activated
receptor
γ
coactivator
1-α)
decreased
activation
mTOR
(mammalian
target
rapamycin).
The
cardioprotective
renoprotective
effects
abolished
specific
inhibition
or
knockdown
autophagy,
AMPK,
sirtuins.
In
clinical
setting,
differentially
increased
proteins
identified
proteomics
analyses
blood
collected
randomized
trials
consistent
with
findings.
Clinical
studies
have
also
shown
gluconeogenesis,
ketogenesis,
erythrocytosis
reduce
uricemia,
hallmarks
principal
statistical
mediators
ability
risk
heart
failure
serious
renal
events.
augment
flux
seen
isolated
cells
tissues
do
not
express
are
exposed
changes
environmental
glucose
ketones
bind
directly
sirtuins
mTOR.
Changes
cardiovascular
physiology
metabolism
cannot
explain
either
experimentally
clinically.
direct
molecular
concept
acts
sensor,
thus,
its
causes
attendant
cytoprotective
effects,
sirtuins,
flux.
Cardiovascular Research,
Journal Year:
2024,
Volume and Issue:
120(5), P. 443 - 460
Published: March 8, 2024
Abstract
An
increasing
number
of
individuals
are
at
high
risk
type
2
diabetes
(T2D)
and
its
cardiovascular
complications,
including
heart
failure
(HF),
chronic
kidney
disease
(CKD),
eventually
premature
death.
The
sodium-glucose
co-transporter-2
(SGLT2)
protein
sits
in
the
proximal
tubule
human
nephrons
to
regulate
glucose
reabsorption
inhibition
by
gliflozins
represents
cornerstone
contemporary
T2D
HF
management.
Herein,
we
aim
provide
an
updated
overview
pleiotropy
gliflozins,
mechanistic
insights
delineate
related
(CV)
benefits.
By
discussing
evidence
obtained
preclinical
models
landmark
randomized
controlled
trials,
move
from
bench
bedside
across
broad
spectrum
cardio-
cerebrovascular
diseases.
With
trials
confirming
a
reduction
major
adverse
CV
events
(MACE;
composite
endpoint
death,
non-fatal
myocardial
infarction,
stroke),
SGLT2
inhibitors
strongly
mitigate
for
hospitalization
diabetics
non-diabetics
alike
while
conferring
renoprotection
specific
patient
populations.
Along
four
pathophysiological
axes
(i.e.
systemic,
vascular,
cardiac,
renal
levels),
into
key
mechanisms
that
may
underlie
their
beneficial
effects,
gliflozins’
role
modulation
inflammation,
oxidative
stress,
cellular
energy
metabolism,
housekeeping
mechanisms.
We
also
discuss
how
this
drug
class
controls
hyperglycaemia,
ketogenesis,
natriuresis,
hyperuricaemia,
collectively
contributing
pleiotropic
effects.
Finally,
evolving
data
setting
diseases
arrhythmias
presented
potential
implications
future
research
clinical
practice
comprehensively
reviewed.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
173, P. 116337 - 116337
Published: Feb. 28, 2024
In
myocardial
ischemia/reperfusion
injury
(MIRI),
moderate
mitophagy
is
a
protective
or
adaptive
mechanism
because
of
clearing
defective
mitochondria
accumulates
during
MIRI.
However,
excessive
lead
to
an
increase
in
and
ultimately
exacerbate
MIRI
by
causing
overproduction
uncontrolled
production
mitochondria.
Phosphatase
tensin
homolog
(PTEN)-induced
kinase
1
(Pink1),
Parkin,
FUN14
domain
containing
(FUNDC1)
B-cell
leukemia/lymphoma
2
(BCL-2)/adenovirus
E1B19KD
interaction
protein
3
(BNIP3)
are
the
main
mechanistic
regulators
Pink1
Parkin
mitochondrial
surface
proteins
involved
ubiquitin-dependent
pathway,
while
BNIP3
FUNDC1
receptor
non-ubiquitin-dependent
which
play
crucial
role
maintaining
homeostasis
quality.
These
can
induce
inhibit
protect
against
but
may
also
trigger
insufficient
mitophagy,
thereby
worsening
condition.
Understanding
actions
these
provide
valuable
insights
into
pathological
mechanisms
underlying
development.
Based
on
above
background,
this
article
reviews
through
Pink1/Parkin
pathway
mediated
led
BNIP3,
as
well
related
drug
treatment,
aim
effective
strategies
for
prevention
treatment
Military Medical Research,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: May 29, 2024
Abstract
Mitochondria,
the
most
crucial
energy-generating
organelles
in
eukaryotic
cells,
play
a
pivotal
role
regulating
energy
metabolism.
However,
their
significance
extends
beyond
this,
as
they
are
also
indispensable
vital
life
processes
such
cell
proliferation,
differentiation,
immune
responses,
and
redox
balance.
In
response
to
various
physiological
signals
or
external
stimuli,
sophisticated
mitochondrial
quality
control
(MQC)
mechanism
has
evolved,
encompassing
key
like
biogenesis,
dynamics,
mitophagy,
which
have
garnered
increasing
attention
from
researchers
unveil
specific
molecular
mechanisms.
this
review,
we
present
comprehensive
summary
of
primary
mechanisms
functions
regulators
involved
major
components
MQC.
Furthermore,
critical
regulated
by
MQC
its
diverse
roles
progression
systemic
diseases
been
described
detail.
We
discuss
agonists
antagonists
targeting
MQC,
aiming
explore
potential
therapeutic
research
prospects
enhancing
stabilize
function.
Free Radical Biology and Medicine,
Journal Year:
2024,
Volume and Issue:
213, P. 19 - 35
Published: Jan. 13, 2024
Overloaded
glucose
levels
in
several
metabolic
diseases
such
as
type
2
diabetes
(T2D)
can
lead
to
mitochondrial
dysfunction
and
enhanced
production
of
reactive
oxygen
species
(ROS).
Oxidative
stress
altered
homeostasis,
particularly
the
cardiovascular
system,
contribute
development
chronic
comorbidities
diabetes.
Diabetes-associated
hyperglycemia
dyslipidemia
directly
damage
vascular
vessels
coronary
artery
disease
or
stroke,
indirectly
other
organs
kidney
dysfunction,
known
diabetic
nephropathy.
The
new
treatments
include
Na+-glucose
cotransporter
inhibitors
(iSGLT2)
glucagon-like
1
peptide
receptor
agonists
(GLP-1RA),
among
others.
iSGLT2
are
oral
anti-diabetic
drugs,
whereas
GLP-1RA
preferably
administered
through
subcutaneous
injection,
even
though
formulations
have
recently
become
available.
Both
therapies
improve
both
carbohydrate
lipid
metabolism,
well
cardiorenal
outcomes
patients.
In
this
review,
we
present
an
overview
current
knowledge
on
relationship
between
oxidative
stress,
therapeutic
benefits
GLP-1RA.
We
explore
benefits,
limits
common
features
remark
how
interesting
target
prevention
obesity,
T2D
diseases,
emphasize
lack
a
complete
understanding
underlying
mechanism
action.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
200, P. 107057 - 107057
Published: Jan. 11, 2024
Mitochondria-associated
ferroptosis
exacerbates
cardiac
microvascular
dysfunction
in
diabetic
cardiomyopathy
(DCM).
Nicorandil,
an
ATP-sensitive
K+
channel
opener,
protects
against
endothelial
dysfunction,
mitochondrial
and
DCM;
however,
its
effects
on
mitophagy
remain
unexplored.
The
present
study
aimed
to
assess
the
beneficial
of
nicorandil
DCM
underlying
mechanisms.
Cardiac
perfusion
was
assessed
using
a
lectin
assay,
while
via
mt-Keima
transfection
transmission
electron
microscopy.
Ferroptosis
examined
mRNA
sequencing,
fluorescence
staining,
western
blotting.
localization
Parkin,
ACSL4,
AMPK
determined
immunofluorescence
staining.
Following
long-term
diabetes,
treatment
improved
function
remodeling
by
alleviating
injuries,
as
evidenced
structural
integrity.
mRNA-sequencing
biochemical
analyses
showed
that
occurred
Pink1/Parkin-dependent
suppressed
cells
after
diabetes.
Nicorandil
mitochondria-associated
promoting
mitophagy.
Moreover,
increased
phosphorylation
level
AMPKα1
promoted
translocation,
which
further
inhibited
translocation
ACSL4
ultimately
ferroptosis.
Importantly,
overexpression
mitochondria-localized
(mitoAα1)
shared
similar
benefits
with
mitophagy,
cardiovascular
protection
injury.
In
conclusion,
demonstrated
therapeutic
revealed
AMPK-Parkin-ACSL4
signaling
pathway
mediates
development
dysfunction.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(9), P. 2274 - 2274
Published: Sept. 14, 2022
Diabetic
patients
are
frequently
affected
by
coronary
microvascular
dysfunction
(CMD),
a
condition
consisting
of
combination
altered
vasomotion
and
long-term
structural
change
to
arterioles
leading
impaired
regulation
blood
flow
in
response
changing
cardiomyocyte
oxygen
requirements.
The
pathogenesis
this
complication
is
complex
not
completely
known,
involving
several
alterations
among
which
hyperglycemia
insulin
resistance
play
particularly
central
roles
oxidative
stress,
inflammatory
activation
barrier
function
endothelium.
CMD
significantly
contributes
cardiac
events
such
as
angina
or
infarction
without
obstructive
artery
disease,
well
heart
failure,
especially
the
phenotype
associated
with
preserved
ejection
fraction,
greatly
impact
cardiovascular
(CV)
prognosis.
To
date,
no
treatments
specifically
target
vascular
damage,
but
recent
experimental
studies
some
clinical
investigations
have
produced
data
favor
potential
beneficial
effects
on
micro
vessels
caused
two
classes
glucose-lowering
drugs:
glucagon-like
peptide
1
(GLP-1)-based
therapy
inhibitors
sodium-glucose
cotransporter-2
(SGLT2).
purpose
review
describe
pathophysiological
mechanisms,
manifestations
particular
reference
diabetes,
summarize
protective
antidiabetic
drugs
myocardial
compartment.